NRC Stock Analysis: Buy, Sell, or Hold?
NRC - National Research Corporation Common Stock (Delaware)
$20.35
-0.97 (-4.55%)
▼
5d:
+3.99%
30d:
+1.7%
90d:
-9.56%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Oct 26, 2026
22d
Get Alerted When NRC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: NRC shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: NRC shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$41.10
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$25.52
20.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NRC is currently trading at $20.35, which is considered oversold relative to its 30-day fair value range of $20.50 to $21.90. The stock's valuation (Forward PE: 19.4) is in line with its historical norms (20.1). Remarkably, the market is currently pricing in an annual earnings decline of 1.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, NRC is in a uptrend. Immediate support is located at $19.18, while resistance sits at $21.96. Short-term momentum is weak, with the stock down 4.5% recently.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $26.00 (+27.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NRC is in a uptrend. Immediate support is located at $19.18, while resistance sits at $21.96. Short-term momentum is weak, with the stock down 4.5% recently.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $26.00 (+27.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$20.50 -
$21.90
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.8%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (43/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.5%)
- BULLISH: Trading 27.8% below Wall St target ($26.00)
- WARNING: Composite score 46/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$20.50 -
$21.90
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$19.18
Resistance Level
$21.96
Current Trend
Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.38
Wall Street Target
$26.00
(+27.8%)
Revenue Growth (YoY)
4.0%
Earnings Growth (YoY)
-44.0%
Profit Margin
4.2%
Valuation Discount vs History
-1.3% cheaper
PE vs Historical
19.4 vs 20.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.3%
(market-implied from PE analysis)
1-Year Target
$20.09
(-1%)
2-Year Target
$19.82
(-3%)
3-Year Target
$19.57
(-4%)
3-Yr Target (if PE normalizes)
(PE: 19→20)
$20.29
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.4, Growth: 218.2%)
$72.29
(+255%)
Base:
(SPY PE: 19.4, Growth: 218.2%)
$68.68
(+238%)
Bear:
(PE: 16.5, Growth: 218.2%)
$58.38
(+187%)
📈
Valuation based on Current Earnings
Forward PE: 17.21 | Forward EPS (Implied): $1.18
Bull Case
$24.57
(+21%)
Analyst growth 15.0%, PE expands to 18.1
Base Case
$20.35
(0%)
Market implied 0.0%, PE stable at 17.2
Bear Case
$15.57
(-24%)
Severe decline -15.0%, PE contracts to 15.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 19.4 to 20.1
Stabilization Target:
$21.11
(+3.7%)
PE Expansion Potential:
+3.7%
Share & Embed Analysis
Last updated: October 02, 2026 8:45 PM ET
Data refreshes hourly during market hours. Next update: 9:45 PM
Data refreshes hourly during market hours. Next update: 9:45 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NRC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 67 BUY |
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$297 | 37 SELL |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 69 BUY |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 60 BUY |
|
EVH
Evolent Health Inc |
STRONG BUY
14 analysts |
$6 | 54 HOLD |
